This study investigates advanced solid tumors. It looks at how the investigational medication works alone and with another treatment.
The purpose of this study is to evaluate the safety, tolerability, and initial effects of the investigational medication. It also examines how the body processes the medication.
- Who can participate: Participants must be 18 years or older with advanced solid tumors and have adequate bone marrow and organ function.
- Study details: Participants will take the study treatment, either alone or with another treatment. Some may receive a placebo.
How understandable was the trial content above?
Hard to understand
Easy to understand